| | NOVEMBER 2021 6EDITOR'S DESKWhile the Covid-19 pandemic swept over the headlines as the new decade began, many biotechnology companies shifted their attention to developing vaccinations, therapies, and diagnostics to fight against the deadly virus. One of the most essential areas of human existence ­ the health sector ­ is being revolutionized by biotechnological technologies. Despite the fact that the industry is heavily regulated, the necessity to service providers, researchers, patients, shareholders, payers, and regulatory authorities while remaining ahead of the pack makes the solutions by this industry highly sought-after. With a significant rise in interest in biosciences such as biology, biotechnology, genetics, and pharmacology, there have been many breakthroughs in the biotech startups environment. For many, the pandemic was a true eye-opener in terms of prospective technological applications in pharmaceutical and biotech businesses. Incidentally, the whole world has rediscovered the importance of industries working on solutions that influence people's lives, such as e-medicine, diagnostics, drug development, gene therapy, wearable medical devices, and many others. Along with the aforementioned advancements, the pharmaceutical industry's biomanufacturing operations are also moving towards automation and digitalization, allowing for more reliable and scalable quality procedures with less room for human mistakes. Moreover, AI and robotics have played a significant role in decreasing production downtime and product waste. When considering the implications of biotech, it is reasonable to believe that numerous companies today are striving to drive the industry's growth this year and beyond, producing novel solutions for a wide range of applications. In the long run, we can all anticipate biotech to play a significant role in many aspects of our daily lives, ushering in a bio-economy. Given the significance of biotech, it is not unexpected that the biotechnology industry has witnessed remarkable growth over the years, and the prognosis for the coming years looks promising.On that note, leafing through these pages will keep you abreast of the most recent and upcoming biotech startups that will help you stay at the forefront of innovation. Let us know your thoughts.At the Forefront of Improving LivesKenneth Thomas Managing Editoreditor@startupcity.comCopyright © 2021 SiliconMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.November - 05 - 2021, Volume 5 - Issue 9 (ISSN 2644-2345)Published by SiliconMedia, Inc. To subscribe to Startup CityVisit www.startupcity.com Editorial StaffAaron Pierce Ava Garcia Mia WilliamsDanny RobinsonJoshua ParkerVian IsaacManaging EditorKenneth Thomas*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffSalesRich Gonsalvessales@startupcity.comVisualizersChris LynnEmailsales@startupcity.comeditor@startupcity.commarketing@startupcity.com
< Page 5 | Page 7 >